首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Gynecologic oncology reports

缩写:

ISSN:2352-5789

e-ISSN:2352-5789

IF/分区:1.3/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引1789
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Katherine Yoh,Marie C Smithgall,Gabriela Tessler et al. Katherine Yoh et al.
Background: Large Cell Neuroendocrine Carcinoma (LCNEC) is a rare and aggressive high-grade neuroendocrine malignancy that only infrequently arises in the uterus. Owing to its rarity, there are no standardized treatment g...
S Ramalho,T Martins,I Pinho et al. S Ramalho et al.
Background: Ovarian cancer is the most lethal gynaecologic malignancy, often diagnosed at advanced stages due to nonspecific early symptoms. Although most patients initially respond to platinum-based chemotherapy, recurre...
Aaryan R Jadhav,Brandon L Fong,Mary R Schwartz et al. Aaryan R Jadhav et al.
Introduction: Extragastrointestinal stromal tumors (EGISTs) are rare mesenchymal neoplasms that originate outside the gastrointestinal (GI) tract and share histologic and immunohistochemical features with gastrointestinal...
Martins Ayoola,Alexandra Smick,Miles Morrow et al. Martins Ayoola et al.
Objective: To evaluate the relationship between genomic instability score and age distribution in ovarian, primary peritoneal, and fallopian tube cancers and to characterize age-related patterns in germline, homologous re...
Ravi Desai,Daniel Bravo,Pelin Onur et al. Ravi Desai et al.
Background: Ovarian Steroid Cell Tumors (SCT) are rare sex cord-stromal tumors accounting for less than 0.1% of ovarian neoplasms. Most are hormonally active and present with symptoms of androgen excess. Steroid cell tumo...
Yushu Wang,Guangyu Ao,Claude Hughes Yushu Wang
Background: Sporadic reports linking human papillomavirus (HPV) vaccination to venous thromboembolism (VTE) have raised safety concerns. We intended to provide an updated and comprehensive evaluation of this potential ass...
Alexa Dzienny,Yasmin Abozenah,James Griffith et al. Alexa Dzienny et al.
Objectives: The objective of this study was to evaluate the efficacy of pembrolizumab and lenvatinib in recurrent endometrial cancer (EC) by platinum resistance status and p53 status, and to compare outcomes between patie...
Elizabeth A Connelly,Christina M Lowry,Chelsea Camara et al. Elizabeth A Connelly et al.
Objective: Limited data exist on pregnancy desires, outcomes, or referral rates in patients with gynecologic hereditary cancer syndromes. This study describes fertility desires and pregnancy outcomes in patients with newl...
Nanami Uetake,Shiho Miura,Yurina Suzuki et al. Nanami Uetake et al.
Background: Mismatch repair-deficient (dMMR) endometrial cancer is highly sensitive to immune checkpoint inhibition. Although pembrolizumab combined with carboplatin and paclitaxel is now a first-line standard treatment f...
Elizabeth Corn,Kelly Becht,Bethel Adefres et al. Elizabeth Corn et al.
Purpose: Cervical cancer is the number one cause of cancer-related mortality for women in Botswana, where care is complicated by the country's severe shortage of gynecologic oncologists. Recent data suggests that "low-ris...